Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals – an application on improving tender decision making in Indonesia

BACKGROUND: Off-patent pharmaceuticals (OPPs) hold vital importance in meeting public health objectives, especially in developing countries where resources are limited. OPPs are comprised of off-patent originals, branded generics and unbranded generics; nonetheless, these products are not identical...

Descripción completa

Detalles Bibliográficos
Autores principales: Inotai, Andras, Brixner, Diana, Maniadakis, Nikos, Dwiprahasto, Iwan, Kristin, Erna, Prabowo, Agus, Yasmina, Alfi, Priohutomo, Sigit, Németh, Bertalan, Wijaya, Kalman, Kalo, Zoltan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310978/
https://www.ncbi.nlm.nih.gov/pubmed/30594250
http://dx.doi.org/10.1186/s12913-018-3805-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310978/
https://www.ncbi.nlm.nih.gov/pubmed/30594250
http://dx.doi.org/10.1186/s12913-018-3805-3

Ejemplares similares